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ABSTRACT 
Bioelectrical impedance analysis (BIA) is a simple tool for assessing body composition. 
Equations used in BIA are developed and validated against a reference method involving 
isotope dilution. Aim: To validate bioimpedance (BIA) against isotope methods for 
determination of body composition in HIV-infected South African children. Objectives: 
l) To establish whether BIA equations currently used for deriving total body water (TBW)
and Fat Free Mass (FFM) in Nigerian and HIV-infected American children are precise to 
be applied to young HIV-infected children in South Africa . 2) To determine feasibility of 
blood and saliva specimens in isotope studies. 3) To compare performance of blood and 
saliva using the isotope dilution method in children aged 3 to 6 years. Methods: 
Anthropometry and Bioelectric impedance measurements were performed on 42 children. 
Bioelectric impedance measurements were done using a 50-kHz tetrapolar BIA device 
(model 101 A; RJL, Detroit). TBW was measured by deuterium oxide (D20) dilution. TBW 
enrichment in blood and saliva was assessed using a Fourier-Transfer Infrared 
Spectrometer. Extracellular water was measured by sodium bromide dilution and was 
assessed using the Perkin-Elmer HPLC system. Results: There was good correlation 
between measured and predicted values for TBW and FFM, and between saliva and blood 
assays of TBW. Despite good correlations, Bland-Altman plots showed poor agreement 
between measured and predicted values of TBW. Bland-Altman plots also showed saliva 
overestimated TBW. Discussion: Children with poor agreement between methods 
appeared to have co-morbidities more frequently than children with good agreement 
between methods. Co-morbidities included oral problems coupled with opportunistic 
diseases which may have caused measurement variation in salivary samples. Altered 
mucosa! permeability may have affected our results by altering absorption and/or 
equilibration time of the isotope. Addition of variables such as reactance, resistance, Z­
score height and height2 (Ht2) improved TBW prediction in our study cohort. 
CHAPTER ONE 
INTRODUCTION 
Since the first discovery of Acquired Immunodeficiency Syndrome (AIDS) in 1981, 
millions worldwide have been affected by this disease. Sub-Saharan Africa lies amongst 
the most severely affected regions with more than 65% of people infected with the Human 
Immunodeficiency Virus (HN) residing here. In South Africa, the HN prevalence rate in 
the 0-5 year age group increased from 2.2% in 2000 to 3.6% in 2006. Common 
manifestations such as wasting and malnutrition seen in diseases such as HN / AIDS and 
cancer cause alterations in Fat Mass (FM), Fat Free Mass (FFM) and Extracellular Water 
(ECW) (Forbes, 1990). Monitoring of body composition during disease provides an 
effective tool for medical evaluation and a predicator of disease progression (Wells and 
Fewtrell, 2006). Techniques such as anthropometry and other sophisticated methods of 
assessment have been used in body composition studies involving children. 
FFM and FM changes can be determined by bioelectrical impedance analysis (BIA). This 
body composition technique determines body fluid volume by measuring resistance to a 
frequency at 50 kHz at a low amplitude alternating electric current of 800µA. The 
resistance is inversely proportional to the liquid volume in the body (Kyle et al., 2004). 
Statistical methods such as regression analysis are used to formulate body composition 
predication equations (Guo et al., 1996). Reference measurements such as isotope dilution 
and variables such weight, height etc, are utilized for the development of predication 
equations. 
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Horlick et al (2002) developed prediction equations for total body water (TBW) and FFM 
in healthy HIV-infected children between the ages of 4 and 18 years. Variables such as 
age, race, sex and HIV-infected/ uninfected were included to improve predictive accuracy 
of the equations. Arpadi et al (1996) tested existing BIA equations in HIV-infected 
Hispanic children aged between 4 and 11 years old. Two prediction equations were 
developed from this study. 
Measurement of TBW allows determination of FFM. This is based on the principle that 
FM is anhydrous and FFM contains a constant proportion of water. Isotope dilution 
provides measurement of TBW in the body. The volume ofTBW can be defined as the 
ratio of a tracer dose to the concentration ofTBW within a time interval. Various tracers 
have been developed for use in isotope dilution studies such as oxygen- I 8, tritium and 
deuterium. However, deuterium is frequently used. Collection of body fluid samples such 




To validate bioimpedance (BIA) against isotope methods for determination of body 
composition in HIV-infected South African children. 
STUDY OBJECTIVES 
• To determine whether equations currently used for determination ofTBW and FFM in
Nigerian and HIV-infected American children from bioimpedance assessment are
precise enough to be applied for use on young HIV-infected children in South Africa 
using isotope dilution as the reference method. 
• To determine the feasibility of blood and saliva specimens for body composition
analysis.
• To compare the performance of blood and saliva using the isotope dilution method in




2.1 INFECTION AND NUTRITION 
Nutritional status can be viewed as an interplay between body composition, body energy 
balance and body functioning (Bedogni et al., 2006). Without proper nutritional intake, 
the immune system lacks essential components that are needed to generate an effective 
immune response, causing a constriction like effect on immune functions, body 
composition and body functioning (Mendez and Adair, 1999). Linings of the 
nasoesphageal, gastrointestinal and the genitourinary system behave as barriers against 
infection. Response to infection requires rapid increases in cell differentiation, replication, 
peptide production and lipid mediators (Scrimshaw and Sangiovanni, 1997). 
A synergistic relationship is observed between nutrition and infection, malnutrition makes 
the body more susceptible to infection. Hence, infection reduces nutrient intake, thus 
leading to malnutrition (Scrimshaw and Sangiovanni, 1997). 
In HIV-infected children we would therefore anticipate both nutritional and infection­
mediated influences on metabolism and body composition. 
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2.2 BODY COMPOSITION 
2.2.1 Definition 
The human body consists of five essential levels, atomic, molecular, cellular, tissue system 
and whole body. The sum of these five levels is equivalent to the body mass (BM) shown 








Figure 2.1: The five levels in relation to body composition. Adapted. from: 
http://www.rowett.ac.uk/edu_ web/sec_pup/body _ comp.pdf. Accessed 19April 2009 
BM is divided into two or more compartments according to various components 
(Heymsfield and Waki, 1991) (Wang et al., 1992). The most common model used to 
describe body composition is the two compartment model whereby body weight is devided 
into two compartments, FM and FFM (Wang et al., 1992). The FM contains extractable 
lipids from adipose tissue and other tissues. The FFM contains water, muscle, bone and 
internal organs. This is the metabolically active constituent of the body, linked to survival 
in various illnesses (Wang et al., 2000). Quantifying body composition into FM and FFM 
is especially important during disease states. Infectious disease is associated with changes 
in relative proprtions of FM and FFM. A lack of nutritent intake during disease more 
specifically in HIV-infected people may implicate development of malnutrition which in 




Childhood malnutrition and more specifically, undemutrition, is a public health concern in 
low to middle income countries. Although much progress has been in this field, it is still a 
problem in many parts of the world. Malnutrition is defined as a sub-acute or chronic state 
of nutrition (Soeters et al., 2008). In the context of this thesis malnutrition will be used to 
describe undemutrition. Malnutrition in adults and children is very prevalent in low and 
middle income countries thus increasing mortality and increased disease burden. 
Undemutrition arising from starvation or reduced intake leads to reduced adipose tissue 
and lean body mass (LBM) though LBM loss is more prevalent. During periods of 
starvation body proteins break down to compensate for amino acid requirements, resulting 
in loss of LBM. Prolonged periods of malnutrition cause linear decline in child growth 
leading to muscle mass retardation (Blossner and de Onis, 2005). As severe loss of LBM 
occurs, the body's response to disease decreases (Suttman et al., I 995). 
There are many different classifications for malnutrition. The WHO classification uses 
wasting as an indicator in disease (WHO, UNICEF, 2009). This is applied in children with 
a weight for height z-score of -3 or less, a mid-upper arm circumference of less than 
11.5 cm or having severe visible wasting or bipedal oedema (WHO, UNICEF, 2009). The 
Wellcome classification is used to classify marasmus, kwashiorkor, and marasmic 
kwashiorkor as severe malnutrition. The Waterlow classification system assesses the 
degree of malnutrition. This classification is based on wasting (inadequate weight for 
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height) and degree of stunting (inadequate height for age) in children. 
Globally, undemutrition is an underlying factor for childhood deaths caused by diarrhoea 
(61 %), malaria (57%), and measles (45%) (Black et al., 2003) 
(Bryce et al., 2005). 
Comparatively, Sub-Saharan Africa has the highest child mortality rate and largest 
malnutrition prevalence in the world as shown in (Fig 2.2). In South Africa malnutrition is 
a factor in 12.3% of deaths (Kibel et al., 20 l 0). The most significant causes of 
malnutrition include inadequate food intake and illness. In 2005, 9.3% of children aged 
1 - 9 years were underweight, 18% were stunted and 4.5% were wasted in South Africa 
(Kibel et al., 20 I 0). The percentage of children in each province affected by stunting, 
wasting and underweight is presented in (Table 2.1 ). 
Table 2.1: Proportion of children affected by stunting, wasting and underweight in each 
province - 2005 (Kibel et al., 20 I 0). 
Pro\'ince Stunting% Wasting% Underneight % 
Eastern Cape 18.0 4.1 7.8 
Free State 28.2 2.8 14.1 
Gauteng 16.8 3.3 14.1 
KwaZulu Natal 15.1 1.3 5 
Limpopo 23.8 4.4 12.3 
Mpumalanga 17.8 7.5 10.9 
North West 15.1 3.2 12.4 
Northern Cape 27.7 19.1 38.3 
Western Cape 12 11.5 8.2 
South Africa 18 4.5 9.3 
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I > 15% malnutrition > 10% malnutrition
> 4% malnutrition
Figure 2.2: Prevalence of child malnutrition. Available. From http://emedicine.medscape.com /article 
/984496-overview. Accessed 24 May 20 I 0 
Malnutrition has been highlighted by the United Nation's Millennium Development Goal 
(MDG) initiative. The first MDG is to halve the amount of people suffering from hunger 
and poverty and the fourth MDG is to reduce under-five mortality by two thirds in the 
same time period (South African MDG Report, 2010). While poverty alleviation programs 
are crucial in the long term, in the short term reduction of mortality from infectious disease 
and undemutrition may be improved by encouraging breastfeeding, promoting 
complementary feeding, vitamin A, zinc, iron and iodine supplementation 
(Kibel et al., 2010). 
Malnutrition often arises as micronutrient deficiencies and protein energy malnutrition 
(PEM) (Emery, 2005) which are further expanded in the proceeding sections. The degree 
and spread of PEM and micronutrient malnutrition depend on factors such as prevalence of 
infectious diseases, breastfeeding, sanitation, availabilty and quality of health services 
(Emery, 2005). In HN-infected persons, micronutrient deficiencies and PEM are 
causative factors for altered growth and development. 
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2.3.2 Micronutrient malnutrition 
Deficiencies in iodine, vitamin A, zinc and iron are common in malnourished children. 
Iodine deficiency is responsible for a large number of infant mortalities, however, this is 
reversible with iodine treatment (Cobra et al., 1997). 
Findings show in-utero exposure to maternal iodine deficiency has damaging effects on the 
developing brain leading to pem1anent cognitive disability (Durkin, 2002). Vitamin A 
plays a role in the immune system whilst iron deficiencies have a detrimental effect in 
development (Bobonis et al., 2006). Severe Vitamin A deficiency can result in 
xerophthalmia. Studies show, this is one of the leading causes of blindness in children 
(WHO, 2002). Apart from effects to the vision, it may also increase the risk of measles 
and other infections resulting in long term disability (Sommer, 1993). Low levels of 
Vitamin A and E are associated with lower CD4+ cell counts in HIV-infected people 
(Tang et al., 1997). 
Within the body, zinc assists in metabolic processes such as Ribonucleic acid (RNA) and 
Deoxyribonucleic acid (DNA) synthesis and plays a vital role in balancing T helper cell 
functions. Deficiency of zinc affects key functions such as gene expression, skeletal 
growth and appetite (Shankar and Parsad, 1998). Mild zinc deficiencies results in 
decreased LBM and severe zinc deficiency leads to weight loss and infections caused by 
cell mediated immune dysfunctions (Prasad, 2003). In a cross sectional study in Malawi, 
findings revealed a high HIV load in pulmonary tuberculosis was linked to micronutrient 
malnutrition (Van Lettow et al., 2004). In HIV-infected children an altered metabolism is 
often linked to micronutrient deficiencies. 
10 
2.3.3 Protein Energy Malnutrition (PEM) 
In children, FFM hydration ranges between 80% in newborns to 75% in IO year old 
children (Hoffer, 200 I). PEM occurs when protein and energy intake are insufficient 
(Hoffer, 2001). Loss of FFM is the main determinant of weight loss in PEM. FFM 
Components such as the skeletal muscles, viscera, blood cells and immune system 
comprises approximately 35 to 50 % of total weight in an adult. Abnormalities in the 
humoral, cellular subsystems, metabolic changes and lack of immune mediators such as 
tumor necrosis factor are common in PEM. 
In children, PEM manifests between the ages of 6 months to 2 years. Severe PEM in 
children is clinically defined as less than 70% weight-to height and/or the appearance of 
pitting edema on both feet which is described as either marasmus, or kwashiorkor 
(Hoffer, 200 I). HIV- infected children with PEM often suffer from growth retardation. 
Marasmus occurs more frequently than kwashiorkor among HIV-infected children below 
the age of 5. Common features ofMarasmus include wasting and growth retardation. 
These features are frequently seen in HIV-infected children. 
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2.4 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
2.4.1 Background 
HIV/AIDS advanced into one of the most disastrous pandemics worldwide. The greatest 
impact of this virus is felt in countries ridden with high levels of poverty. Worldwide, 
countries such as South Africa and China have the highest incidence of HIV/ AIDS 
(Kilmarx, 2009). 
Early reports of the disease were discovered in young homosexual men with rare diseases 
then such as Kaposi's sarcoma, persistent Lymphadenopathy and Pneumocystis carinii 
(PCP) (Siliciano, 200 I). The virus is transmitted via blood transfusion, sexual activity, 
breastfeeding, perinatal mother to child transmission and accidental inoculation 
(Siliciano, 200 I). 
HIV can be classified either into HIV- I and HIV-2. They belong to the subfamily 
Lentivirinae of the family Retroviridae. A characteristic feature of this family is the 
presence of a Ribonucleic acid (RNA) genome and reverse transcriptase. They have 
similar genetic makeup, origins and cell tropism. HIV-2 has a lower replication rate, cell 
dissemination and CD4 interaction. Only two subtypes of HIV-2 have been characterized 
with subtype A being the major variant. HIV-2 has a smaller virulence factor and a longer 
progression time compared to HIV-I (Whittle et al., 1994). 
Worldwide HIV-infection continues to increase in children. Globally HIV/AIDS is one of 
the main leading causes of death in children. 
12 
2.4.2 Epidemiology Worldwide 
In 2008, 2.0 million people died due to AIDS and a total of 33.4 million adults and 
children below 15 years were infected with HIV/AIDS (AIDS epidemic update, 2009. 
UN AIDS). Approximately 90% of infected children reside in sub-Saharan Africa. 
Figure 2.3: Number of people living with HIV. Available. From 
http://data.unaids.org/pub/EPIS1ides/2009/2009 _ epiupdate_ core_ en.ppt#264, 4, Slide 4. 
Accessed 13 June 20 I 0 
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2.4.3 South Africa 
The growth of HN prevalence in South Africa took place primarily between 1993 and 
2000, during which time major political changes were taking place. Whilst attention was 
focused on the transition from apartheid, HN was becoming more prevalent. In 2008, 5.6 
million South Africans were HN-infected. HIV infections and AIDS related deaths differs 
within each province in South Africa as depicted in (Fig 2.4). Kwazulu-Natal has 
approximately 1.6 million people whom are RN-infected and 300 000 are still requiring 









/□ New HN infections(over the year) ■ AIDS deaths(over the year) / 
Figure 2.4: New HIV infections and AIDS related deaths in 2008 (Nathea, 2008) 
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Children have a short window period between the transition from HIV-infection to AIDS. 
Thus many childen that are unable to access treatment often die befor the age of two 
(Monson et al., 2006). Between 2008-2009, the number of children in Sub-Saharan Africa 
receiving ARVs increased from 224100 to 296000 as shown in (Table 2.2) 
(WHO, UNICEF,UNAIDS, 2010). Factors such as poor access to health care facilities, 
poverty and lack of availability of AR Vs contribute to children not receiving ARVs on 
time (Posse et al., 2008). Rights of children especially the right to health treatment is 
often undermined in many areas in Sub-Saharan Africa. 
Table 2.2: Number of children living with HIV younger than 15 years receiving 
antiretroviral therapy, needing antiretroviral therapy and percentage coverage 
according to region (WHO, UNICEF,UNAIDS, 2010). 
Geograph1ca Report number o Estimateci number of Antiretroviral therapy 
j-Pon children (0-14 years) children needing coverage among 
receiving antiretroviral antiretroviral therapy children [range) 
296 000 1 140 000 26% (19%-42%} 
Eastern and 254 900 790 000 32%[25-48%] 
southern Africa [530 000-1 000 000] 
West and central 41 000 350 000 12% [8%-22%] 
Africa [180 000-510 000] 
Latin America and18 600 32 200 58% [45%-80%} 
the Caribbean (23 000-42 000) 
Latin America 16 300 24100 
(19 000-31 000] 
68% (52-87%] 
The Caribbean 2400 8100 29% [19%-5 7%] 
[4100-12 000] 
East, South and 36 500 83400 44% [27%-59%] 






North Africa and 560 10 000 6% [4%-11%] 
the Middle East L5200-1 s 0001 
Total 356400 1 270 000 28% [21 %-43%) 
15 
2.4.4 Prevalence of HIV/ AIDS in children in South Africa 
HIV prevalence rate in the 0-5 year age group increased from 2.2% in 2000 to 3.6% in 
2006. As shown in (Table 2.3) HIV prevalence rates differ amgonst all the provinces in 
South Africa with KZN having the highest rate (Monson et al., 2006). 
Table: 2.3: The HIV-prevalence rate among children in South Africa from 2000 to 2006 
(Monson et al., 2006). 
� � � 
Pw.1oce 'I(, % 'i, 
EaSlern Cape 1.0 1.2 1.4 
Free State 1 5 1.7 2.0 
Gauteng 1.4 1.7 1.9 
KwaZulu-Natal 2.1 2.4 2.6 
Lirrpopo 0.8 0.9 1.1 - - --
Mpumalanga 1.8 2.0 2.2 
Northern Cape 0.5 0.6 0.7 
North West 1.3 1.5 1.7 
Western Cape 04 0.4 0.5 
South Africa 1.2 1.5 1.6 
2.4.5 Morbidity and Mortality in children 
� �· "i.'..!.".1 ....
% � 'I(, % 
1.6 1.7 1.9 2.0 
2.2 2.3 2.5 2.6 
--
2.1 2.2 24 2.5 
2.8 3.0 3.1 3.2 
1.2 1.3 1.3 1.4 - -
-- -
2.4 2.5 2.6 2.6 
0.8 0.9 1.0 1.1 
1.9 2.0 2.1 2.2 
06 0.7 0.7 0.8 
1.8 1.9 2.0 2.1 
The number of child deaths in South Africa is still extremely high with most being 
preventable. An important factor that influences the child mortality rates is the HIV/AIDS 
pandemic (South African MDG Report, 2010). Studies done show that post-neonatal death 
rates are increasing the infant mortality rate (IMR), thus increasing the under-five mortality 
rate (U5MR) (Sanders et al., 2010). The main cause of these deaths is HIV/AIDS (South 
African MDG Report, 2010). 
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The Millennium Development Goal 4 (MDG 4) commits countries to reduce the under-five 
mortality rate by two thirds between 1990 and 20 I 5. Comparatively to other countries 
child mortality trends in South Africa have showed no major improvement over the past 15 
years. The estimated under five mortality rate in 1990 for South Africa was 60 deaths per 
1000 live births. However the MDG 4 target is to reduce under five mortality to 20 deaths 
per I 000 live births (South African MDG Report, 20 I 0). This is unlikely to be achieved as 
shown in the table (Table 2.4). 
Table 2.4: Millenium Development Goal 4 - Reduce Child Mortality in South Africa by 
2015. (South African MDG Report, 2010). 
Goat and lndk:atol"• , ____ Cwrena :l'etfi T .. _ -·-




Under-five mortality rate 20 
(1998) (2007) 
54 53 
Infant mortahty rate 18 
{2001) (2007) 
Proportion of 1 year-old 68.5 98.3 
children immunised 
against measles (2001) (2009) 
Immunisation coverage 66.4 95.3 
under 1 year of age (2001) (2009) 
Life expectancy at b<rth for 57.6 64.8 55.3 
60.4 
(200 (200 70 males and females (2001) 
1) (2007) 7) 
Diarrhoea incidence under 138.0 132.6 Not 
5 years of age (per 1,000) No target applicable Domestic (2001) (2009) 
Pneumonia incidence 21 102.1 Not under 5 years of age (per No teri.,et 
applicable 
00tnestic 
1.000) (2003) (2009) 
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2.4.6 HIV infection in children 
More than 90% of children living with HIV are infected through mother-to-child 
transmission (MTCT) during pregnancy or via breastfeeding (Newell, 2001). MTCT of 
HIV can occur in-utero, intrapartum and postpartum. During pregnancy a child has a 
5-10% risk of getting infected, during labor they have a 10-20% risk of getting infected
and a I 0-20% risk of getting infected via breatfeeding (de Cock et al., 2000). 
Transmission during pregnancy may occur due to membrane rupture or via placental 
infection. Findings show a 2% increased risk of HIV infection occurs during the duration 
of every hour of a membrane rupture (The International Perinatal HIV Group, 2001 ). 
These findings emphasize the need of cesarean section prior to labor and membrane 
rupture. A randomized clinical trial in European women showed efficacy of cesarean 
section as a preventive measure for MTCT. The transmission rate was lower in cesarean 
section ( 1.8%) versus vaginal delivery (10.5%). An 83% efficacy was found in this trial. 
(The European Mode Of Delivery Collabration, 1999). 
Prolonged duration of breastfeeding increases the risk of HIV infection in a child 
(The breastfeeding and HIV International transmission study group, 2004). Risk of HIV 
infection via breastfeeding depends on factors such as breast infection (John et al., 2001 ), 
pattern of breast feeding (exclusive versus mixed) (Coutsoudis et al., 1999) 
(Coutsoudis et al., 2001) and maternal viral load (Dunn et al., 1992). 
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In a prevention of mother to child transmission (PMTCT) study carried out in South 
Africa, children born to HIV-infected women had a higher mortality than those born to 
uninfected mothers (Newell et al., 2004). Immunosupression and opportunistic infections 
are apparent in HIV-infected children within their first year. Children with rapid 
progression are infected in-utero and are unable produce an effective immune response 
(Lambert et al. 1997). Decreased weight and linear growth are common features of growth 
failure in children. Prolonged periods of weight loss are often linked with secondary 
infections (Macallan, 1993). 
HIV infection in children differs from that of adults, disease progression occurs rapidly and 
their viral loads are much higher. Opportunistic infections arise frequently in children 
often affecting nutritional status in children. Other important factors such as alterations in 
food intake, nutrient absorption and energy expenditure also affect the nutritional status in 
HIV-infected children (Andiman et al., 1994). These are further expanded in the following 
section. 
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2.5 NUTRITIONAL CHANGES ASSOCIATED WITH HIV 
2.5.1 The wasting syndrome 
HIV associated wasting is often seen in the advanced stages of HIV (Clinical stages 3 and 
4). In adults it is defined as more than I 0% loss of body weight and a decline greater than 
2 percentile lines with chronic diarrhoea or fever in children older than a year 
(Bailey et al., 1999). The wasting syndrome is an AIDS defining illness and plays a role in 
mortality and morbidity. In adults severe wasting is identified by a body mass index 
(BMI) less than 18.5 kg or an unintentional weight loss of more than 5% body weight 
within a 6 month period (Grinspoon et al., 2003). In young children, wasting is linked 
with LBM loss (Arpadi et al., 1996). 
In HIV associated wasting, two forms of malnutrition exist, starvation and cachexia. 
Starvation is defined as the deprivation of food leading to weight loss. Physiologic and 
biochemical changes that occur during starvation include decreased energy expenditure 
and increased lipid oxidation. Cachexia is defined as a disproportionate loss of LBM as 
compared to FM (Kotler, 2000). The loss ofLBM and poor linear growth in HIV-infected 
children is closely associated with poor survival (Morley et al., 2006). 
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Paeditric HIV-infected patients with HIV associated growth failure have an increased risk 
of morbidity and mortality (Bo bat et al., 2001 ). In a cross sectional study, before 
commencement of ARV therapy, 50% of HIV-infected children were stunted or 
underweight and one in five had developed wasting (Eley et al., 2006). In a cohort of HIV 
positive children in South Africa, a high percentage of children were stunted compared to 
being underweight (Bachmann et al., 2006). Elevated levels of HIV replication is linked 
with growth failure (Arpadi et al., 2000). 
Contributing factors to the HIV wasting syndrome include alterations in food intake, 
nutrient absorption and energy expenditure (Melchior et al., 1991 ). Decreased intake of 
nutrients is often associated with various factors such as gingivitis, esophagitis and 
enteritis (Fox, 1991 ). This was evident in our study cohort. Inflammation of the upper 
gastrointestinal tract caused by various infections and ulcers promote the development of 
anorexia (Kotler et al., 1992). 
Side effects caused by certain medications exacerbate the development of anorexia. 
HIV-infected children have a higher percentage of abnormalities caused by infections such 
as cytomegalovirus, Candida albicans or herpes (Miller et al., 1993). Central nervous 
system (CNS) processes such as dementia or tumors also affect nutrient intake in 
HIV-infected patients (Mintz, 1996). 
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Intestinal malabsorption is a common feature in HIV-infected patients and a contributing 
factor of malnutrition in AIDS (Koch et al., 1996). Causative factors of malabsorption 
include HIV induced atrophy, enzyme deficiencies and opportunistic infections such as 
cryptosporidiosis, Mycobacterium tuberculosis and salmonella (Winter and Chang, 1993). 
Resting metabolic rate is a pertinent factor in individuals with HIV/AIDS. Rapid weight 
loss associated with secondary infections cause increased resting energy expenditure 
(Grunfeld et al., 1995). Cytokines, such as TNF, IL-1, and IL-6, cause increased 
metabolism, muscle catabolism and negative nitrogen balance during infection 
(Ridkr et al., 1997). 
In a comparative study done by Melchoir et al ( 1993) resting energy expenditure was 11 % 
higher in HIV-infected patients compared to control subjects and in HIV patients with co­
infections, resting energy expenditure was 34% higher than in control subjects. Suttaman 
et al ( 1993) made a correlation between resting energy expenditure and weight loss in 
HIV-infected adults. All clinical stages displayed increased resting energy expenditure. 
HIV-infected children rapidly lose FFM during the initial stages of disease 
(Fontana et al., 1999). This may have consequences in terms of prognosis and response to 
therapy. Assessment of body composition in HIV-infected children provides insight in 
growth and development in relation to disease progression. 
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2.6. BODY COMPOSITION CHANGES IN DISEASE 
Paediatric diseases negatively impact body areas such as fat, bone mineral density and 
muscle mass. Body composition analysis allows quantification of vital tissue components 
such as LBM and FM. Therefore, understanding the principles of total body composition 
assessment allows health care workers to 1) Monitor body composition changes associated 
with disease 2) To assess nutritional interventions in altering body composition 3) To 
monitor growth 4) To monitor development and age-related changes in body composition 
(Heyward and Wagner, 2004). 
Various studies illustrate changes in body composition that occur in relation to disease. A 
Study done on paediatric patients on artificial ventilation showed LBM depletion 
(Wells et al., 2002). ICW and ECW is higher in stunted children, this is revealed in a 
study that compared techniques for evaluation of adiposity in stunted and nonstunted 
children (Hoffman et al., 2006). 
Common body composition changes in HIV-infected individuals include fat redistribution, 
increased visceral adipose tissue and decreased subcutaneous adipose tissue. Loss of 
muscle mass reduces functional status and strength in HIV positive individuals 
(Grinspoon and Mulligan 2003). Children with HIV associated growth failure have a 
lower percentage of FFM as compared to the FM component (Arpadi et al., 2001). 
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The use of appetite stimulants present an alternative for increasing caloric intake in HIV 
infected persons. An increase in nutritional intake in children with HIV-associated growth 
failure using appetiate stimulants improves weight without any improvement on FFM. 
This is shown by findings from a double-blinded, placebo-controlled trial of megestrol 
acetate (Megace®,Bristol Myers Squibb, Princeton, NJ), which revealed an increase in 
weight gain. However, BIA analysis showed a larger increase in FM as compared to FFM 
(Kotler and Grunfeld,1996). ARV therapy has a positive effect on growth and body 
composition (Miller et al.2001) (Verweel et al. 2002). This was observed in a paediatric 
group on Highly Active Antiretroviral Therapy (HAART) in South Africa. The findings 
are illustrated in the table below (Table 2.5) (Reddi et al. 2007). 
Table 2.5. Growth changes in HIV infected children < 15 years after I year on HAAR T 















A number of body composition techniques have been developed for use in various disease 
settings such as anthropometry, BIA, isotope dilution and imaging methods. These will be 
discussed further in the subsequent section. 
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2. 7 BODY COMPOSITION TECHNIQUES
2.7.1 Anthropometry 
Anthropometry is a common body composition technique used in clinical studies. It is an 
inexpensive and non-invasive technique. Recent developments in this field involve 
calibration of anthropometric measurements against reference estimates of body 
composition to develop various prediction models. Basic anthropometric measurements 
such as body height, weight and skinfold thickness are utilized for determining nutritional 
status as shown in (Fig 2.5) (Wang et al., 2000). 
Circumference 








Chin Supra scapular 
Chest Sut:scapular 
Width 















Figure 2.5: Anthropometry measurement areas (Wang et al., 2000) 
Studies using anthropometry provide vital background of nutritional disorders reflected in 
diminished triceps, skinfold thickness or other measurements illustrating body fat 
(Miller, 1993). Skinfold thickness is used as a predictor for body fatness since 40-60% of 
total body fat is located in the subcutaneous region within the body (Wang, 2000). 
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BMI defined as Wt/Ht2 provides childhood fat estimates in large epidemiological studies 
(Brodie et al., 1998). A variation in BMI during childhood emphasizes the need for age 
and gender specific reference standards (Cole et al., 2000). 
The sub-scapular, triceps and MUAC illustrate LBM and fat stores in children older than 
one year. Measurements are applied in multiple regression models to derive equations for 
calculation of body density, body fat (adiposity) and FFM (Miller, 1993). Skin fold 
measurements used in clinical or field settings can then be used to estimate body 
composition (Wells et al., 1999). 
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2.7.2 Bioelectrical Impedance Analysis (BIA) 
BIA is a body composition technique that is used to derive TBW measurement and hence 
estimate FFM and adiposity. It is a quick, simple, portable and non-invasive technique that 
could potentially provide accurate results with small interobserver variability (Segal et al., 
1991 ). The history of BIA goes back since 1871. Today it is widely used in various 
research settings for a number of diseases. 
2.7.2.1 Principle of BIA 
An electrical current is able to pass easily through blood and urine while bone and fat have 
large impedance (Z) and do not conduct significant current. Current thus flows through 
materials with higher conductivities (O'Brien et al., 2002). BIA is based on the 
relationship between volume of the human body (conductor), length (height), components 
(FM/FFM) and Z. It is possible to estimate body composition by assuming the conductor 
is a perfect cylinder as shown in (Fig 2.6). Voltage (V) the parameter measured with BIA 
is produced between two electrodes. It is often expressed as a ratio V/I. This ratio known 
as Z is the function of two components, resistance (R) which is normally 250.Q and 
reactance (X) which is 10% the amount of resistance (Kyle et al., 2004). Magnitude of Z 
is similar to R. Z and R can be applied as if they are interchangeable although 
(Equation 2.1) (Dittmar and Reber, 2001) 
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Resistance of a conductor is proportional to its length (L) and inversely proportional to its 





A (Equation 2.2) (Kyle et al,, 2004) 
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Figure 2.6: A cylinder model for Bioimpedance Analysis. Adapted from: 
http://www.jawon.co.kr/eng/technology/body-composition/principles-of­
bia.php. Accessed 12 April 2009 
Since conductivity and resistivity is not constant, body water volume can be determined by 
(Equation 2.3) (Kyle et al., 2004). The resistance index (Ht2/R) is often applied to predict 









Where R is the resistance of the body, pis the resistivity, Lis the conductor length, Vis the volume of water 
and Hr is Height2 
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BIA measures the opposition of body tissues to the flow of an electric current. A cur ent 
(/), of about 800 mA at a frequency of 50 kHz is introduced into the body. The current 
passes between two electrodes, called the source and detector. This generates voltages 
between different points in the body volume according to Ohms law. The electrodes are 
usually located on the wrist and ankle shown in (Fig 2. 7) below. 
-c11--•·--·
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Figure 2.7: Electrode placement for Bioimpedance Analysis. Adapted from: 
http://www.rjlsystems.com/support/docs/analyzers/general/placement/. Accessed 12 April 2009 
2.7.2.2 Background of Validation 
In body composition studies, a new or existing body composition method is valid when it 
provides an estimate that is close to the value obtained in a criterion method. However 
accuracy of the method tested is often determined by size of the prediction error 
(Lohman, 1992). Often cross validation is the final aspect of validating a new or existing 
body composition assessment method. In the cross validation process, the assessment 
method being evaluated is often applied to estimate body composition in an independent 
group in order to determine how strongly the method predicts body composition as 
compared to the criterion method. An independent group often comprises of a new, 
representative sample of individuals (Manore et al., 2009). 
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The body composition assessment method being tested is considered accurate and precise 
if results from the cross validation study indicate prediction errors and reliability estimates 
for the body composition variables are within acceptable ranges (Manore et al., 2009). 
2. 7.2.3 Prediction equations
To achieve an accurate prediction of TBW in an individual a prediction equation validated 
for subjects of overall body composition similar to that subject is required 
(Kyle et al., 2004). Errors in calculation of FFM from BIA assessment arise from the 
assumptions that: I) A 50-kHz current passes freely through cell membranes and body 
fluids and 2) Body water distribution is uniform throughout the body (Kyle et al., 2004). 
This may result in inaccuracies in conditions with disturbances in extracellular vs. 
intracellular water distribution or in instances such as wasting conditions or short stature. 
BIA prediction equations are either population-specific or generalized (Ainsworth et al., 
1997). Theoretical and empirical relationships between FFM, TBW and bioimpedance 
measures estimate FFM and TBW. BIA equations developed that are population-specific 
account for differences in age, ethnicity, gender, physical activity and level of body fat. 
These equations are valid and can be applied to individuals with similar characteristics to 
those in the specific study group (Wells. 2006). Generalized BIA equations vary in age, 
gender, body fatness and ethnicity. These equations account for variability between 
populations via inclusion factors such as age and gender used as predictor variables in 
estimating FFM or TBW. Ris a better predictor of FFM and TBW than Z since the size of 
R is larger than X (at a 50 kHz frequency) when measuring whole body impedance 
(Houtkooper et al., 1989). 
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In order to account for the complex body shape, body weight and individual differences in 
body size are included in BIA prediction equations. Predictive accuracy of BIA equations 
is improved by inclusion of body weight, Ht2 and R in BIA prediction equations 
(Kushner et al., 1992). A number of regression equations have been developed using BIA 
alongside other techniques such as dual-energy X-ray absorptiometry (DEXA), 
anthropometry and isotope dilution to predict FM, FFM and TBW. 
Goran et al (1993) incorporated age into a prediction equation using 26 preschool children 
to obtain FFM. Arpadi et al (1996) tested existing BIA equations in HIV-infected 
children. Addition of sex, weight and height had no improvement on the predication of 
TBW and FFM. Majority of the study subjects were Hispanic and ages ranged between 4 
and 11 years. 
BIA prediction equations have been developed in HIV-infected prepubertal children 
(Arpadi et al., 1996). Prediction equations for estimating body cell mass, FFM and TBW 
in HIV-infected adults have been developed (Kotler et al., 1996). Horlick et al (2002) 
developed prediction models for TBW and FFM in healthy HIV-infected children aged 
between 4 and 18 years. Variables such as age, race, sex, HIV-infected/ uninfected were 
added to improve the predictive accuracy of the equations.A study carried out by Faisy et 
al (2000) showed good correlation between BIA and DEXA in paediatric patients with 
chronic inflammatory disorders. In a longitudinal study involving obese women, 
correlation was observed between BIA, FFM and deuterium dilution (Kushner et al., 
1990). 
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2.7.3 Isotope dilution 
2. 7.3.1 Introduction
Water is located in all tissues, organs, cells and compartments such as the ICW, plasma, 
interstitial water, dense connective tissue and transcellular water (Mattsson and Thomas, 
2006). TBW makes up 73% of the FFM in normal healthy individuals (Kotler, 1999). In 
infants TBW consists of 80-83% FFM, however this declines till hydration becomes 
comparable to that of adults (Fomon and Nelson, 2002). Measurement of BM and TBW 
permits calculation of FFM. The amount ofTBW within the body alters during various 
conditions (Kotler, 1999). 
Measurement ofTBW is carried out using isotope dilution. Tracers used for TBW analysis 
include titrated water, deuterium water and 18 0 - labeled water. Assumptions that arise
with TBW measurement by isotope dilution are I) The tracer is distributed only in body 
water. 2) The tracer is equally distributed in all anatomical water compartments. 
3) Equilibration rate of the tracer is rapid. 4) Neither tracer nor body water is metabolized
during the time period of tracer equilibration. The intercept and the equilibration methods 
are often used to measure TBW. The intercept method requires a longer time period 
between 7 to 14 days (Haisma et al., 2003). 
The equilibration method is more advantageous as it requires a considerably shorter time 
period as compared to the intercept method. Equilibrium after oral administration requires 
a time period of 3-4 hours. 
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2. 7 .3.2 Principle
The volume of a compartment is defined as the ratio of a tracer dose given orally to its 
concentration in the body compartment within a time period after dose administration. The 
tracer enrichment in the body water pool is carried via collection of body fluids such as 
saliva, blood or urine samples. The first sample is collected before the dose is given. The 
second sample is collected after a certain time period. This time period allows for 
sufficient equilibration of the tracer within the body compartment. This process is depicted 
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Figure 2.8: Schematic diagram depicting isotope dilution. Adapted from: 
http://www.iaea.org/NewsCenter/Features/Nutrition/energyintake.html. Accessed 26 October 
2009 
As isotopes enter the body, H isotopes and O isotopes undergo non-aqueous exchange. 
Specifically, hydrogen exchanges with exchangeable atoms in body protein and other non­
aqueous components, but most of the exchange is with protein. By labelling water 
molecules it is possible to measure body water. If the water molecule is labeled in one of 
the hydrogen positions with the stable isotope deuterium, it will distribute throughout the 
water pool and reach a near steady state concentration (Racette et al., 1994). 
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TBW is composed of two compartments, intracellular water (ICW) and ECW. ICW is the 
fluid phase found in organs and muscles whilst ECW is distributed in interstitial fluid, 
connective tissue fluids and plasma. Alteration of the ECW compartment occurs during 
disease and is characteristic of various diseases such as endocrine disorders, congestive 
heart failure, cirrhosis and liver disease (Geerling et al., 1999). 
Infection and various inflammatory illnesses lead to lowered serum albumin levels by 
decreasing albumin synthesis and increasing ECW. In conditions such as heart failure, 
arterial circulation is the main determinant of water retention in the body thus expanding 
ECW (Uszko et al., 2006). Renal problems also lead to alterations in water metabolism. 
Increase or decrease in water and sodium is associated with metabolic alterations followed 
by oedema (Woodrow et al., 2005). 
A number of factors such as sex, race, age, weight, and height influence interpretation of 
ECW. In disease, ICW changes are less obvious as compared to ECW. Usefulness in 
ECW monitoring with other nutritional measurements allows determination of nutritional 
status in those with acute and chronic diseases (Kim et al., 1999). ICW is calculated as the 
difference between TBW and ECW (Bedogni et al., 1997). 
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Various tracers such as Bromide (Br), chloride (Cl), thiocyanate, thiosulphate, sulphate, 
insulin, sucrose and mannitol have been used for measuring ECW. Br and Cl approximate 
ECW well however, no suitable radioisotope for chlorine exists. Thus Br as sodium 
bromide (NaBr) may be used as a tracer to determine ECW (Mattsson and Thomas, 2006). 
The administration of Br allows rapid exchange with body chloride and the volume 
distribution of Br is equivalent to that of Cl. The use of Br has a good absorption, slow 
excretion and slight penetration into tissues (Mattsson and Thomas, 2006). A study by 
Snel et al ( 1995) determined body composition in adults with growth hormone deficient 
(GHD) by measuring ECW directly using Br dilution. ECW was estimated in children 
with malaria (Planche et al., 2004) and in low birth weight infants (Mayfield et al., 1991 ). 
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2.7.4 Measurement of Total Body Water by Deuterium 
2. 7.4.1 Fourier Transform Infrared Spectrometry (FTIR)
Figure 2.9 The Thermo Scientific Nicolet 380 FTIR Spectrometer. Available from: 
www.thermonicolet.com. Accessed 26 October 2009 
FTIR is an infrared spectrometry technique used in various research areas including body 
composition research. Data obtained from measuring deuterium concentration in saliva or 
plasma samples enables TBW measurement. In FTIR, absorption in the infrared region of 
the electromagnetic spectrum is linked with the vibrational energy of the 0-H and 0-D 
bonds. The absorption band at 2504cm·' is used to determine the deuterium content of an 
aqueous sample. Thus, the intensity of this band is linearly related to the concentration of 
deuterium in the sample (International Atomic Energy Agency (IAEA), human health 
series, 2009). 
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2. 7 .4.2 FTIR instrumentation 
lnferometers composed of a beam splitter, splits incoming infrared beams into two optical 
beams. One beam reflects a fixed flat mirror whilst the other beam reflects off a flat mirror 
placed on a mechanism. The two beams are recombined when they meet again at the beam 
splitter (Introduction to Fourier Transform Infrared Spectrometry). Available from: 
www.thermonicolet.com.[Accessed 23 January 2010]. The signal exiting the inferometer 
is called an interferogram. 
The interference patterns of the modulated signals from the interferogram are amplified, 
digitised, electronically stored and transformed into a spectrum via a mathematical 
technique known as the Fourier transformation. This decodes the individual frequencies. 
A computer performs the Fourier transformation and the spectral information is obtained 
(Beekes et al., 2007). 
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2. 7.5 Measurement of extracellular water (ECW) by NaBr dilution 
2.7.5.1 High performance liquid chromatography (HPLC) 
High performance liquid chromatography (HPLC) can be used to assess Br concentrations 
in plasma and saliva. HPLC is widely used in body composition for ECW determination. 
This technique has already been implemented in various research areas. The eluent is 
filtered and pumped through a chromatographic column. The sample is loaded and 







Figure 2.10: The PerkinElmer HPLC system, Series 200 liquid chromatograph. (PerkinElmer Series 
200 HPLC System) Available from: www.perkinelmer.com. Accessed 26 October 2009 
Analysis of Br using the PerkinElmer HPLC system is performed as follows: There are 
four solvent reservoirs located in a closed chamber. The Series 200 Liquid Chromatograph 
delivers the solvents. The pump system connected with a helium gas tank moves solvents 
through the system. The autosampler deposits samples at the top of the column. The Br is 
separated from other compounds by the anion column. The detector of the PerkinElmer 
Model series 200 spectrophotometer measures absorbance in the wavelength range l 90nm-
700nm. The Series 200 Laboratory computing integrator digitises the analog signal from 
the chromatograph, plots the chromatogram, detects, integrates the peaks and produces a 
report. (The PerkinElmer Series 200 HPLC System). Available from: 
www.perkinelmer.com.[Accessed 23 January 2010). 
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2.7.6 Air Displacement Plethysmography (ADP) 
Air displacement plethysmography(ADP) is body composition technique that has replaced 
underwater weighing. The subject in placed in a device composed of an air filled chamber. 
The device consists of two chambers, the subject is placed in one chamber and the other is 
a reference chamber. When the subject is placed inside the chamber, pressure is increased 
and the diaphragm separating the two chambers is oscillated to produce a volume and 
pressure change in each chamber (Ellis, 2000). Comparative analyses between ADP and 
underwater weighing have shown good results in adults and children (Lockner et al. 2000). 
2.7.7 Neutron Activation 
This method applies the principle of activating the body with a known amount of neuron 
energy. When the body is exposed to neutrons, y- rays are emitted. The induced 
radioactivity is counted in a whole body counting chamber. A known dose of neutrons 
generates a known amount of activity within a defined mass of a substance (Ellis, 2005). 
Various factors such as the detection system used and body position within the neutron 
field influence the validity of the technique. Common elements measured are total body 
calcium and total body nitrogen. The determination of total body nitrogen allows 
estimation of LBM. This technique is limited due to radiation exposure to children and 
pregnant women (Ellis, 2000). 
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2. 7.8 Imaging methods 
Common body imaging methods include computer tomography (CT), magnetic resonance 
imaging (MRI) and DEXA. However these methods cannot be considered as valid field 
methods for body composition due to high investment, highly trained technical staff, 
expensive maintenance and service costs. 
2.8 BODY FLUIDS AND ISOTOPE DILUTION 
In adults, equilibrium ofICW and ECW occurs within 3 hours. The most frequent body 
fluid collected for isotope dilution is plasma as it allows rapid equilibration of the tracer. 
Urine however, has shown to be less reliable as compared to blood and saliva due to the 
longer isotope equilibration time in the bladder (Schoeller et al., 1980). 
The usage of urine or saliva samples are non-invasive and can be used in children. In a 
comparative study by Schoeller et al ( 1982) saliva and serum were compared after isotope 
ingestion in obese children. There was no difference in saliva samples collected at the 3 
hour interval compared to the 4 and 6 hour blood samples. The isotope equilibration was 
found to be rapid between serum and saliva samples. In another study by Horlick et al 
(2002) who evaluated predictive BIA equation in children aged 4 to 18 years old, saliva 
samples were collected for isotope dilution analysis. 
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3.1 STUDY COHORT 
CHAPTER THREE 
METHODS AND MATERIALS 
We recruited a total of 42 children from the King Edward VII Hospital paediatric HIV 
clinic, the paediatric wards at King Edward VII Hospital and Clairwood Hospital in 
Durban. A number of body composition studies used children above the age of 4 years, 
thus excluding earlier periods when more dramatic changes occur in body water and body 
composition. In order to address this gap in knowledge, this study included male and 
female children between the ages of 3 to 6 years. Due to the 3 hour fasting period and 
collection of saliva, inclusion of infants in this study would have been problematic. 
All study subjects were attending routine follow up for preparation for ARV treatment. 
There were no restrictions on ethnicity of subjects. Subjects at different stages of HIV 
disease severity and differing nutritional status were included. Children were included into 
the study only when their parent, or legal guardian provided informed consent/assent and 
they were between 3 and 6 years of age. Children were excluded from the study if they 
were on any current or previous treatment with megestrol acetate or corticosteroids. 
Glucocorticoids were allowed if used more than 2 weeks prior to study entry, and duration 
of treatment in past 6 months did not exceed 2 weeks. Other exclusions were any current 
febrile illness, cardiac or renal failure, abnormal losses through diarrhoeaor vomiting at 
time of assessment, clinical features of dehydration, on diuretic therapy, presence of 




Ethical approval was obtained from the Biomedical Research Ethics Committee, Nelson R 
Mandela School of Medicine, South Africa (Re/number: £049/05) (Appendix F), and 
hospital management approval from King Edward VIII Hospital and Clairwood Hospital. 
Prior to assessment, all patients were given consent forms (Appendix D) that were 
translated into Zulu and study was explained to parents and caregivers before they signed. 
Standard case record forms were used to document assessments in this study (Appendix E). 
3.3 SAMPLE SIZE 
Our original crude sample size estimates were based on the sample sizes used in equivalent 
studies in the literature as well as the project's budgetary constraints. Arpadi et al (1996) 
studied 20 prepubertal children for a similar study design and aim, Leman et al (2003) 
studied 39 children. We calculated that using an average of these two sample sizes, a 
sample size of 30 children would allow us to account for 97% of the variance observed in 
TBW. We further anticipated 20% loss of usable data arising from inadequate specimen 
quality which could be due to inadequate volumes, breakage during transport or accidental 
contamination of specimens in transit (although standard precautions were in place to 
avoid this). Thus a total sample size of 36 was targeted. The development of new 
equations requires much larger sample sizes so this activity would be purely exploratory 
and provide the preliminary data for subsequent research. 
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3.4 STUDY PROCEDURES 
Study reruitment and assessment was done between August 2008 to November 2009. 
After obtaining informed consent participants were given an appointment and instructed to 
arrive at the study site on the scheduled morning. They were instructed to omit morning 
meals but to ingest any prescribed medication as per schedule. All anthropometric 
measurements were recorded in duplicate using standardized technique and the average of 
both measurements used. 
3.5 WEIGHT 
Weight was recorded using a portable digital scale and measured to the nearest 0.1 kg. 
Calibration of the scale was done on a daily basis using standard weights and checking the 
zero value. All footwear and clothing except a light vest and undergarment was removed 
prior to being weighed. 
3.6 HEIGHT 
A fixed wall-mounted stadiometer was employed for measuring standing height. All 
subjects were required to stand on the stadiometer (Seca, Kraaifontein, South Africa) 
without shoes with the back of the head, shoulder blades, buttocks, calves and heels 
touching the posterior board. The head was positioned so that the child was looking ahead 
thus, the external auditory meatus and lower margin of the orbit were aligned horizontally 
(the Frankfort plane). The headboard was pulled down firmly onto the crown of the head 
and height was recorded to the nearest 0.1 cm. All measures were done in duplicate to 
increase accuracy. 
43 
3.7 MID UPPER ARM CIRCUMFERENCE {MUAC) 
Study subjects were asked to stand upright with their right arm bent 90 degrees at the 
elbow. All clothing such as jerseys, long sleeved shirts covering the arm was removed 
prior to measurement. 
A mark was made on the uppermost edge of the posterior border of the spine extending 
from the acromion process. A measuring tape was held at this mark and extended down 
the posterior surface of the arm to the tip of the bony part of the mid-elbow. A midpoint 
was recorded and marked. The measuring tape was wrapped around the arm at the level of 
the upper arm mid-point mark and a measurement was taken in duplicate. 
3.8 BIO-ELECTRICAL IMPEDANCE ANALYSES (BIA) 
For BIA measurements, the single-frequency 50-kHz tetrapolar BIA device (model 101 A; 
RJL, Detroit) was utilized. All study subjects were placed supine with their arms and legs 
slightly abducted. Skin sites were disinfected first with alcohol swabs prior to placement 
of the electrodes. All measurements were performed on the right side of the body. Two 
pairs of electrodes were placed on the right hand and foot. Measurements were taken when 
subjects were quiet and not moving. Subjects were measured within 10 minutes of lying 
supine and measurements had to be done at least 4 hours after the last meal. Direct 
measurements of resistance and reactance values that were recorded were later used to 
compute TBW using the prediction equations found below in section 3.8.1. 
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3.8.1 BIA prediction equations 
Leman et al (2003) developed and validated the use of regression equations to predict 
TBW in Nigerian children aged 5-18 years. It was found that impedance index was the 
most significant predictor ofTBW and weight and gender explained much of the 
remainder of the variability. The limitation in generalizing this to our population of 
interest is that these children were older than 4 years of age and did not appear to be 
HIV-infected. The difference between HIV infection and starvation is that the former is 
linked with FFM loss early in its course with concurrent loss of FM in more advanced 
disease. The latter usually has a reversed pattern of alteration in body compartments. 
Arpadi et al (1996) was among the first to test existing BIA equations in HIV-infected 
children. They developed two regression equations that could be employed in their sample 
cohort because none of the equations they tested adequately predicted TBW or FFM. 
Unlike the Nigerian group they found that gender and weight did not significantly improve 
predictive value. Most of the children in their sample had moderate to severe symptoms of 
HIV infection; which is similar to our study cohort. The limitation is the predominant 
Hispanic background of these children and, once again, the age range did not include 
children below the age of 4 years. Thus, after considering the equations below, we decided 
to test our measurements against the equations developed by Arpadi, Horlick and Leman 
on our study population. 
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a) Log (TBWD20) = 1.65 + 0.05 ht
2 (cm)/Resistance (ohms) (Equation 3.1) 
(Arpadi et al., 1996)
b) TBW = 1.18 + 0.42 (ht2/resistance) + 0.18 (wt) (Equation 3.2) 
(Leman et al., 2003)
c) TBW = 1.00 + 0.60 (ht2/resistance) (Equation 3.3) 
(Leman et al., 2003)
d) TBW = 0.725 + 0.475 ht
2/resistance + 0.140(wt) (Equation 3.4) 
(Horlick et al., 2002)
e) FFM = [3.474 + 0.459 ht2/resistance + 0.064wt] (Equation 3.5) 
[0.769-0.009A-0.01S] 
(Horlick et al., 2002) 
f) TBW = 0.76 + 0.18 ht
2/I + 0.39 wt (Equation 3.6) 
(Fjeld et al., 1990)
g) TBW = 0.7 ht
2
/resistance -0.32 (Equation 3.7) 
(Kushner et al., 1992)
h) TBW = 0.593 ht
2 
resistance+ 0.065 wt + 0.04 (Equation 3.8) 
(Kushner et al., 1992)
Where TBW is total body water, ht is height in cm, wt is weight in kg,/ is impedance, A is age in years, Sis 
sex with male= ! and female=O. 
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3.9 ISOTOPE DILUTION 
TBW was measured by 2 hour D20 dilution and ECW by a 2 hour Br dilution. Body 
composition study packages were supplied by the Body Composition Unit of St Luke's 
Roosevelt Hospital, New York. Each package contained l dose vial containing a 
predetermined fixed dose (0.5 ounce) of deuterated water, 2 green top tubes, 2 plastic 
specimen tubes with cap and I study information sheet. Each patient's initials, the date of 
study and the study name were recorded on the patient information sheet. A unique 
number was allocated to each child and this number was used to label all samples obtained. 
Participants were advised not to eat at least two hours before the test. 
At time zero (after the BIA measurement) and before dose administration, two dental rolls 
were placed at the side of the inner cheeks for a time period of 10-15 minutes for saliva 
collection. Saliva was collected in a specially marked tube called "pre dose saliva". 
Thereafter venipuncture was performed and blood ( 4ml) was collected in a specially 
marked green top collection tube labeled "pre dose blood". 
The dose vial was opened and poured into an empty cup to avoid spillage. The empty dose 
vial was tapped against the cup to allow complete emptying of the dose vial. To ensure 
complete emptying of the dose vial 5ml of fruit squash was added to the dose vial and the 
cap replaced, shaken and poured into the cup. Subjects were asked to drink the dose as 
quickly as possible. All dose cups were rinsed 3 to 5 times with fruit squash to ensure 
complete ingestion. After 2 hours a second blood sample ( 4ml) was collected in specially 
marked green top collection tubes labeled "post dose blood". All pairs of blood samples 
were marked with a study number. Blood collected in pre and post dose blood tubes were 
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centrifuged (ALC multispeed refrigerated centrifuge (PK121R)) at 3000rpm for 10 
minutes. Thereafter plasma was transferred to pre and post dose plasma tubes and stored at 
-20°C until shipment. At 3 hours, saliva (2ml) was collected by placing two dental rolls at
the side of the mouth for a time period of 10-15 minutes to ensure sufficient collection of 
sample in specially marked tube called "post dose saliva". Saliva collected in pre and post 
dose saliva tubes were centrifuged (ALC multispeed refrigerated centrifuge (PK121R)) at 
3000 rpm for 10 minutes. Thereafter saliva was transferred to pre and post dose specimen 
tubes and stored at -20°C until shipment. 
At the end of the study all samples were shipped on dry ice to the body composition 
laboratory at St Luke's Roosevelt Hospital in New York. D20 enrichment was measured 
with a Fourier- Transfer Infrared Spectrometer (Appendix C). TBW was then calculated 
by a standard formula and pre-/post- status. The HPLC system (Perkin - Elmer HPLC 
system, and the series 200 Liquid Chromatograph) was used for the measurement of 
extracellular water (Appendix C). 
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3.10 MEASUREMENT OF TOTAL BODY WATER BY DEUTERIUM OXIDE 
3.10.1 Stock and standard dose preparation and storage 
D2O (99.8 % atom.JOO grams/bottle, ID 2084, ICON, NJ) was used as the stock dose and 
stored in a refrigerator. The stock and working standards (Appendix A) were prepared and 
stored in a refrigerator. 
3.10.2 Procedure 
The Fourier - Transfer Infrared (FTIR) Spectrometer (Avatar 360 with software OMNIC 
ESP 5.0, Nicolet Wisconsin) was used for spectrometric analysis. Prior to spectrometric 
analysis approximately I ml of sample was lyophilized to total dryness and residuals were 
condensed in a test tube, sealed and stored under refrigeration until spectroscopic analysis. 
Quality control (Appendix A) and calibration was performed prior to reading samples. The 
FTIR system was calibrated with working standards before reading of samples. The 
concentration of D2O in each specimen was calculated from the standard calibration. TBW 
was calculated using the following equation: 
TBW (Liter) = D2O / (post dose-pre dose) / 1.04 
(Ellis and Wong, 1998) 
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(Equation 3.9) 
3.11 MEASUREMENT OF EXTRACELLULAR WATER (ECW) BY SODIUM 
BROMIDE DILUTION 
3.11.1 Stock and standard dose preparation and storage 
Measurment of ECW was undertaken by Sodium Bromide Dilution using an HPLC system 
(Perkin - Elmer HPLC system, and the series 200 Liquid Chromatograph) . Stock 
solutions (Appendix B) were prepared and stored in a refrigerator. Standard preparations 
(Appendix B) were also prepared and stored in a cabinet at room temperature. Quality 
control of newly prepared stock solutions were carried out (Appendix B). 
3.11.2 Procedure 
The following preparations were carried out before the HPLC readings: 
(I) 0.1ml Pre sample+ 0.9ml water
(2) 0.1ml Post sample+ 0.9ml water
(3) 0.1 ml Pre sample+ 0.8ml water+ 0.1 ml 800uM Standard.
Each sample was vortexed and filtered through an ultra free filter unit ( cat# UFP I TGCBK, 
Millpore). The sample (3) was the spiked sample used for calculating post Br 
concentration. 1 00ul of filtered sample was injected into the sampler with a microsyringe. 
The injection syringe was washed with acetone thoroughly after every sample. 
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3.12 DATA ANALYSIS 
Data analysis was performed using the SPSS statistical software version 15.0 and SAS 
statistical software version 9.2 (SAS Institute Inc, Cary, NC). Estimation of FFM and 
TBW was undertaken from bio-impedance measures using selected published prediction 
equations. We then validated against TBW measured by dilution. We used several 
measures of validation, including correlation, rank correlation, root mean squared error, 
and average differences (the last to estimate bias). We also used the Bland-Altman 
approach to determine the agreement between methods. To derive new equations for TBW 
and FFM we used regression techniques and inclusion of independent variables such as 
weight, height, age, gender, Ht2/resistance and Ht2/reactance. We selected the best models 





4.1 STUDY COHORT CHARACTERISTICS 
This study began in 2008. We recruited 42 black children, of whom 23 were females 
(55 %). Seventeen children were aged 3-4 years, 9 were aged 4-5 years and the remainder 
5-6 years. We had fairly restricted racial and age distribution so we do not expect these to
be a major source of confounding in the outcome of results. 
All subjects met clinical eligibility criteria for commencing ARV therapy. Two children 
had mild HIV disease with WHO clinical stage 2, 27 had stage 3 disease and 13 had stage 
4 disease. While we would have preferred to have better representation of stage 2 disease 
the numbers reflected here were representative of the profile of children in the study age 
group who were commencing ARV therapy in the treatment program at the time of the 
study. All children were afebrile at time of study. 
We screened a total of 61 children, 18 patients were not enrolled because parents declined 
participation or did not arrive to sign the consent form, and one child died unexpectedly 
before consent or recruitment. We therefore enrolled a total of 42 children. Chronic co­
morbidities were common among these children. A total of 35 samples were used for 
analysis of blood and 23 samples were used for saliva analysis. 
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Some of the characteristics of the children with inadquate samples include concurrent 
tuberculosis, wasting and oral pathology, oral problems such bleeding gums, dental caries, 
mouth sores, chronic lung disease and other chronic diseases. 
These children had varying nutritional status based on anthropometry. 21 % out of 42 were 
stunted and 14% were wasted. Average anthropometic and body composition parameters 
of our study cohort are displayed in (Table 4.1) below. 
Table 4.1: Measured and derived body composition parameters of study patients 
Physical characteristics '.\1ean (SD) 
Weight (kg) 12.98 (2.71) 
Height 93.35 (7.36) 
Mid upper arm circumference 14.69 (]. 72) 
Weight-for-age z score 0.00 (I .00) 
Height-for-age z score 0.00 (1.00) 
TBW (plasma deuterium) [n = 35] 9.48 (2.12) 
ECW ( plasma Br) [n = 39] 4.89 (1.27) 
Mean ratio of ECW(NaBr) to TBW 0.53(0. 12) 
Fat Free Mass (kg) [median, variance] 10.9 (3.7) 
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4.2 COMPARING THE RELATIONSHIP BETWEEN TBW MEASURED BY 
DEUTERIUM AND TBW PREDICTED BY SELECTED EOUA TIONS 
Objective one: To establish whether equations currently used for the determination of 
TBW and Fat Free Mass (FFM) in Nigerian and HIV-infected American children from 
bioimpedance assessment are precise enough to be applied for use on young HIV-infected 
children in South Africa using an isotope dilution method as the reference method. We 
assessed these through correlation and Bland-Altman plots of agreement. 
TBW predicted by Leman (Equation 1) had the strongest correlation with measured TBW 
(r= 0.522). Horlick (r = 0.506) also had a good correlation. Leman (Equation 2) 
(r = 0.437) and Arpadi (r = 0.439) had moderate correlation with measured TBW. The use 
of scatter plots (Fig 4.1 to 4.4) show a fair linear relationship was present between 
measured and predicted values. The relationship was statistically significant but the 
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Figure 4.1: Plot of linear correlation between measured TBW and TBW predicted 



















Figure 4. 2: Plot of linear correlation between measured TBW and TBW predicted 
using Leman equation (Leman et al., 2003) (Equation 2) 
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Figure 4.3: Plot of linear correlation between measured TBW and TBW predicted 














Figure 4.4: Plot of linear correlation between measured TBW and TBW predicted 
using Horlick equation (Horlick et al., 2002) 
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Agreement between methods using the Bland-Altman method is summarized in 
(Table 4.2) and shown in (Fig 4.5 to 4.8). 
Table 4.2: Agreement between predicted TBW using existing equations against measured 
TBW (L) 
EQUATION BIAS* 95°/., LIMITS OF AGREEMENT 
(Leman et al., 2003) (equation 1) -1.34 
(Leman et al., 2003) (equation 2) -1.90 
(Arpadi et al., 1996) -0.40 
(Horlick et al., 2002) -1. 72 
-4.93 to 2.24 
-5.81 to 2.01 
-4.16 to 3.36 
-5.37 to 1.93 
*Bias refers to the difference between TBW measured through isotope dilution and TBW estimated from the
described equation 
The Bland-Altman plots of agreement indicate that all equations tended to underestimate 
TBW. Again, examination of those children showing poor agreement on these plots 
revealed that those children with the most extreme underestimates on predicted equations 
showed more severe co-morbidities. Fifty percent of those children having bias worse than 
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4.3 FAT FREE MASS ASSESSMENT 
4.3.1 Relationship between FFM derived from measured TBW and FFM was 
predicted by use of existing equations using Bio-impedance measures 
FFM derived from measured TBW showed the relationship was statistically significant 
with the strongest correlation 0.55. The Bland-Altman plots of agreement indicated little 
bias (0.22) with the Horlick et al equation showing better precision as shown in 
(Table 4.3). 
Table 4.3: Agreement between predicted FFM using existing equations against FFM 
derived from measured TBW 
EQUATION BIAS 95% LIMITS OF AGREEMENT 
(Arpadi et al., 1996) 
(Horlick et al., 2002) 
0.22 
0.22 
-4.19 to 4.63 






























Figure 4.9: Plot of linear correlation between measured FFM and FFM predicted 
using (Horlick et al., 2002) 






Figure 4.10: Plot of linear correlation between measured FFM and FFM predicted 
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Figure 4.12: Bland-Altman Plot of agreement between measured FFM and (Arpadi et al., 1996) 
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4.4 COMPARISON OF THE USE OF BLOOD AND SALIVA SPECIMENS FOR 
BODY COMPOSITION ASSAYS 
Objective two: To determine the feasibility of blood and saliva specimens in isotope 
studies and to compare the performance of blood and saliva using the isotope dilution 
method in children aged 3 to 6 years. Saliva collection was difficult in some children and 
there were several specimens with volumes below I ml. There were six samples that 
produced implausible saliva values ranging from 27 to 326L for TBW. These were 
eliminated from subsequent analyses. 
After elimination of the six implausible salivary values, Pearson's correlation between 
TBW blood and saliva was very good (r = 0. 78) (Fig 4.13). Mean (SD) for TBW blood 
was 9.48L (2.12) and for TBW saliva 10.IOL (2.25). 
This study found from the Bland-Altman plots (Fig 4.14) that saliva over-estimated TBW 
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Figure 4.14: Bland-Altman Plot of agreement between TBW blood and TBW saliva 
measurement 
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4.4.1 Characteristics of children with poor correlation between blood and saliva. 
Of the 42 children, nine children with poor agreement had co-morbidities. We found that 
five of these nine children had oral lesions, namely severe gingivitis with dental caries or 
blisters; and one of them also had TB meningitis. Only two of the children with good 
agreement, that is bias above - l .3L up to IL, had mild oral lesions and one had chronic 




The main goal of this study was to determine whether prediction equations used in 
Nigerian and HIV-infected American children were precise enough to be applied for use in 
young HIV -infected South African children using the isotope dilution method as the 
reference method. 
The application of existing equations to our population was of interest due to the paucity of 
appropriately developed predictive equations in this population. Subjects from the 
prediction studies used had no opportunistic infections or they were relatively healthy. The 
data presented in this study showed predicted and measured TBW values had a poor 
agreement. We postulate that this may be due to altered isotope equilibration or to altered 
bioelectric impedance; and offer rationale for these below. 
Our study cohort had a high prevalence of various chronic opportunistic infections or 
conditions coupled with HIV. The breakdown of intestinal mucosa! barrier with microbial 
translocation is a major factor in HIV progression (Lackner, 2009). This maybe suggestive 
that an increased intestinal permeability and epithelium damage may have affected the 
outcome of our results by altering absorption and equilibration time of the isotope; hence 
leading to an overestimation of TBW values from the measured isotope. Tests such as the 
lactulose-mannitol test which assesses intestinal permeability have been applied in HIV 
studies (Lima et al., 1997). 
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The loss of mucosal integrity leads to increased lactulose absorption and the absorption of 
mannitol is decreased due to loss of absorptive space (Fleming et al., 1990). In a study 
with patients in the advanced stages of HIV, it was found that mannitol excretion was 
decreased (Pe met et al., 1999). In another study Stockmann et al ( 1998) showed increased 
lactulose levels in HIV-infected patients with duodenal impaired epithelial barrier function. 
Our cohort may have also had abnormalities such as altered intra- and/or extracellular 
hydration that affected conductivity and ultimately affected our results as compared to 
other predictive studies. A previous study has demonstrated altered extracellular to 
intracellular water ratio in longitudinal follow-up of stunted children (Hoffman et al., 
2006). We postulate that stunting coupled with catabolism arising from serious co­
morbidities may further alter this ratio. 
Previous studies have shown that HIV-infected children have a lower percentage of FFM 
compared to normal healthy children (Miller et al., 1993) (Fontana et al., 1999). We found 
our study cohort had a relatively low FFM even when anthropometric Z scores were not 
severely affected. This maybe attributed to our study cohort having preferential and 
inappropriate catabolism of muscle mass, as seen in cachexia rather than long-lasting semi 
starvation. This is further supported by a study in American HIV infected children whom 
had diminished FFM as compared to FM (Arpadi et al., 1998). 
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Agreement between FFM derived from measured TBW and FFM prediction equations by 
(Arpadi et al., 1996) and (Horlick et al., 2002) showed a good correlation with Arpadi 
(r= 0.548). However in our Bland-Altman plots, poor agreement was observed with 
prediction equations used. This was seen by the Arpadi equation overestimating FFM as 
compared to the Horlick equation. Despite attention to standardized measurements, 
remaining error in measurement may be possible. 
The second aim in our study was to determine feasibility of blood and saliva specimens for 
body composition analysis and to compare the performance of blood and saliva using the 
isotope dilution method in children aged 3 to 6 years. A number of studies have shown 
good results in using saliva for TBW analysis (Horlick et al., 2002) (Arpadi et al., 1996). 
In our study there was a good correlation between TBW blood and saliva (r = 0.78), 
however, Bland-Altman analysis revealed saliva overestimated TBW although an adequate 
equilibration time was employed. We found a large number of our study subjects with 
poor agreement between saliva and blood TBW measurements, had oral problems coupled 
with opportunistic diseases. 
We discuss below possible reasons for this observation. Various substances cross the 
mucosa] barrier either by transcellular, intracellular or pass between cells via intracellular 
routes (Squier and Kremer, 2001). Findings from a study by (Hoogstraate and Bodde, 
1993) showed tracer penetration was limited at the boundary of granular and keratinized 
layers of the oral mucosa and failed to penetrate the epithelium sufficiently. This may be a 
mechanism at play in our study children with oral ulceration. 
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Findings from a study by Kaufman et al (2002) showed serum may reach saliva either 
from the gingival crevicular fuid, through the oral mucosa and from the salivary glands 
affecting oral mucosa! integrity. In a study by (Sweet et al., 1995) it was seen that 
C.albains isolates from HIV subjects adhered in vast numbers to the buccal epithelial cells
causing alteration in the epithelial cell surface. Studies done related to the buccal mucosa 
showed that compounds pass through a thicker membrane with an increase in lag time 
(Nicolazzo et al., 2003). 
In this regard, our findings may suggest that changes in the oral mucosa due to infections, 
co-morbidities and breakdown of mucosa! intergrity due to oral lesions, presence of blood, 
caries and other oral manifestations may be an eminent factor for measurement variation in 
salivary samples. This may be due to incomplete absorption of isotope or 'entrapment' of 
isotope in oral mucosa resulting in higher salivary levels of isotope, i.e. we may be 
measuring isotope entrapped in mucosa or salivary glands rather than that absorbed from 
intestine and entering saliva through equilibration. 
A review of the predictive value of existing equations shows that they had excellent 
predictive values in the study populations that they were developed and validated in. The 
variables included in these equations explained 95% to 99% of the variance in TBW in the 
published studies. In our study however these variables explained only up to 30% of the 
variance in TBW using Arpadi equations, and less for the other equations. We therefore 
explored additional variables in multiple regression models and found reactance to be an 
important predictor. 
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The following equation: TBW= -3.8 + 0.13(Ht) +0.07(reactance) -0.004(resistance) 
(Equation 5.1) had an R2 of 0.54 and root-MSE of 1.5. Even though it still leaves much 
unexplained variance it has better predictive value than existing equations. The 
unexplained variance may be related to the nature of chronic co-morbidities in our study 
population. This however requires further validation. 
As per description on page 52, we restricted participation to a fairly homogenous age 
group to overcome the variability associated with age. In terms of performance of BIA and 
salivary measures it is conceivable that age may have affected outcomes. Untreated HIV 
in young children is likely to be associated with subclinical mucosa) and body composition 
changes that affect the performance of these measures. These children are also more likely 
to have more advanced HIV disease than older cohorts. 
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CONCLUSION 
In conclusion, the present study demonstrated that predicted and measured TBW had poor 
agreement in our population. Co-infections coupled with HIV seen in patients in this study 
may have adversly affected the performance of predictive equations used. Thus far to our 
knowledge this is one of the first studies evaluating the performance and modification of 
predictive equations developed in other countries for use in South African HIV infected 
children. We offer additional variables for use in predictive equations specific for our 
population. While saliva samples are usually preferable for isotope studies in young 





The development of new equations in this study was exploratory and hence
provides preliminary data for subsequent research that aims to validate new
equations. Findings from this study may contribute to future clinical and
community-based studies to reliably document changes in body composition in
HIV-infected children.
2. The use of Bioirnpedance method in practice
The use of bioimpednace in non-invasive, inexpensive and portable. This
technique has shown to work well in healthy persons as well as those with chronic
illness. Futhermore, BIA as revealed in this study has the ability to predict TBW
and intracellular and extracellular water. In practise, this is a very valuable
technique that can be used in individuals with HIV, thus monitoring changes in
body composition and proper nutritional interventions can be set up. BIA appears
to be a useful non-invasive technique to assess body composition in HIV-infected
children as young as 3 years of age in the absence of clinically apparent co­
morbidities. In those with clinically apparent comorbidities its ability to predict
body composition is more limited.
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APPENDICES 
APPENDIX A: PREPARATION OF STANDARDS FOR TBW BY DEUTERIUM 
OXIDE AND QUALITY CONTROL 
A) Stock standard preparation
For the stock standard (15.0mg/ml), l 5000gram of D20 stock was weighed and diluted
to 15mg/ml with deionised water in a 1000ml graduate flask.
B) Working standard
Six working standards were prepared with concentration ranges of 0.0, 0.15, 0.30, 0.45,
0.60 and 0.75mg/ml in water by weighing the stock standard. These were used for
assay calibration.
C) Quality Control
A dose of D20 was weighed and added to an 8 litre plastic bottle containing 6000ml of
dH20. This mixture is called phantom The D20 concentration in the phantom was
measured before assays were done. The D20 dilution volume in the phantom was
calculated as the dose weight divided by the post equilibrium D20 concentration in the
phantom. The ratio of the calculated phantom volume to the pre set volume of 6000ml
is the quality control index. If the quality control was >0.95< the assay procedure was
repeated.
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APPENDIX B: STOCK, STANDARD DOSE PREPARATION AND STORAGE 
FOR MEASUREMENT OF EXTRACELLULAR WATER {ECW) 
BY SODIUM BROMIDE DILUTION 
Stock dose solution prepartion 
A) Pre-prepration
NaBr: Purified NaBr purchased from Fisher scientific (Cat#S255-500) was dried in an
oven at so0c prior to preparation of the stock solution.
Water: Water that was used for solution preparation and Br assay was deionized with a 
deionizing system (Cat# FCR of 1001, ZWDJ 02531,zwdj 02532,Ion Pure, Lowell,Ma) 
and filtered with a 0.2 um filter unit ( Cat# 1260020,Nalgene Company, Rochester,NY) 
Glassware and plastic containers: All glassware and containers that was used for 
making the stock colutions and Br assays were rewashed with the filtered ionic free 
water 
B) Stock solution
NaBr was weighed to 411.6gram and dissolved in 500ml of water in a 1000ml
volumetric flask. Water was added till the 1000ml mark and mixed until it was 
completely dissolved. This step was repeated 4 times to make up 6 litres. After 
mixing, a 300ml aliquot of the stock solution was transferred to a plastic bottle. Each 
stock solution bottle was labelled with date, concentration, date of expiration and 
stored in a refrigerator. 
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C) Quality control for stock solution
The Br concentrations of newly prepared stock solutions were measured on the HPLC
system and compared with the working standards that were currently used on the same
day. A paired t test was used to test the differences. If a significant difference (p<0.05)
was observed for any standard, it was remade and if a significant difference for any two
standards was observed, the stock solution was remade.
D) Preparation of working standards
A diluted stock solution (200mM/I) was made by taking 5ml of the stock solution into
a 100ml volumetric flask and adding water to the 1 00rnk mark. The solution was
mixed and labelled. Working standards of 200,400,600 and 800uM/ 1000ml were made
in a 1000ml volumetric flask with I ml, 2ml, 3ml, and 4ml of the diluted stock solution.
Each standard was capped, labelled with date and concentration and stored.
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E) Quality control before sample analysis
An 8 litre bottle filled with 6 litre of water measured accurately was used as the
phantom. An NaBr dose was weighed on each study day. The dose was injected into
the phantom and then thoroughly mixed. The daily assay quality was tested by
measuring the following three specimens prepared in a test tube ( cat# 14-162-
10D,Fisher) prior to assay in the subject's specimens.
(1) 0.1ml pooled plasma + 0.9ml water
(2) 0.1 ml pooled plasma + 0.1ml taken from a phantom prepared daily for quality
control test+ 0.8ml water
(3) 0.1ml pooled plasma+ 0.1ml 600uM working standards+ 0.8ml water
Each tube was mixed on a vortex for l0seconds. The samples were then filtered 
through an ultra free (1 0.000NMWL) Filter unit ( cat#UFP ITGCBK, Millipore). The 
quality control samples were read the same as patient samples. The quality control 
score was calculated by using the peak area readings of the three samples with the 
following equation on a PC system: 
QC % = (NaBr dose for phantom / (phantom concentration x 6)) x 100% 
QC% = (((Nabr dose weight (g) for phantom x 4 M) / 1.28) /(((sample 2 -
samplel) / (sample 3 - samplel)) x 600)/ 6) x 100% 
Where 4M is the stock dose concentration, 1.28 is the specific gravity of the stock solution, and 
600uM is the working standard concentration used/or the QC test. 
If the QC% was >2 Z-score of the accumulated QC%, the HPLC system was 
readjusted. 
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F) Purging the HPLC system
Purging of the HPLC system was done using the following three steps: 
I) The reservoir chamber door was opened to allow helium gas to bubble through the
solvents for approximately 5 minutes, therafter the chamber door was closed.
2) Increase in reservoir pressure was held between 7-9psi
3) When steady state pressure was reached, the system was ready for purging. A 10ml
syringe was connected to the flush port. Water was used to purge the system and the
flow rate was automatically set. The drain valve was opened and the water solvent was
drained into the syringe automatically. When bubbles were expelled the purging step
was complete. The steps above were repeated using NaCl. During flushing with the
NaCl solution, the detector was adjusted until the baseline was stabilized at "O". The
system was then ready for sample assays.
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APPENDIX C: EXAMPLE OF LABORATORY ASSAY DATA 
DATE OF ASSAY 
RECOVERY DATE: 
REC DOSE WEIGHT (gm) 
REC DOSE(meq)=DOSE WT .. 4/1.28 
HPLC READINGS: 
POOL ED PLASMA: 
POOLED PLASMA+ REC 
SPIKED POOL ED PLASMA: 
SPIKING STD CONC 






SYRINGE +Br DOSE 
BR DOSE WEIGHT: 
BR DOSE (meq) = dose wt"4/1.28 
H PLC READINGS: 
O' SALIVA: 
120' SALIVA 
SPIKED O' SALIVA 
SPIKING STD CONC.: 
CALCULATION 
N ET 180'= 
NET SPIKED STD= 
180' SALIVA CON= 
ECW= BR DOSE(meq)/pl con 


























Figure 4.15: Assay data for the analysis ofECW by Sodium Bromide Dilution 
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DEFAULT REPORT 
P .. T irne [ ... Are.a.[µ'iJ· 5] Height[µ'iJ] Are.a.[\] Norm .•. BL Are.a/Height [ 5] 
4 3.292 26. ?2 39.51 0.00 0.00 BB O.ti?ti4
5 3.823 10. ?8 31.15 0.00 0.00 BB 0.3459 
6 4.058 16 .53 n.n 0.00 0.00 BB 0.4383 
? 4.391 2?48. 34 95.29 0.15 0.15 BB 28.8423 





















THE TBV\/ MEASURED BYDD USING FT-IR 
12/1112)00 OPERATOR: wen 
A REA FOR CROSS-VALIDATION 
0.00 0.1 5 03) 0.45 O.ElJ 0.75 
-0.0300 0.4;Je4 1.0<llO 1.8323 2.1774 2.7839 
0.0072 0.:'.663 1.1172 1.6374 2.1921 2.003 
-0.0510 O.fil62 1.1007 1.7008 22012 2.7825 
O.CG65 0.:'.673 1.1011 1.6477 22270 2.8650 
0.04::9 0.6305 1.1fil3 1.7447 22339 2.7639 
0.0104 0.5775 1.1433 1.0034 2.2217 2.8134 
Q_()q45 0.0141 0.0431 0.0502 0.0184 O.Cffl8
0.0000 0.5371 1.1332 1.673:I 2.2113 2.8030
0.:'.671 0.0031 0.5l;l8 0.5383 O.fil17 
3.712 /nteroe{:t: 0 D0035 R: 0.3398 SE.E.: 










y = 3.7119x +0.0059 
R2 = 0.9998 
0.00 ¥-----...-----+-----1-------1
0.0150 
0.00 0.20 0.40 0 .60 0.80 
CONCENTRATIOr� (mg/ml) 
REC 10125'00 DOSE WEIGHT: 2.2J2J8 GRAMS 
MEAN SD 
O' READING: -0.0450 0.0511 -0.0220 O.O<B4 -0D3:lJ -OD@ 0.044}3
180' READING: 1.38B3 1.33e4 1.3799 1.::G57 13770 1.3817 0.01211 
CONCENTRATION: 0.372 mg/ml 
RECOVER)t'.%) 98.5 % 5. 91222
Figure 4.17: FTIR standard curve and readings for TBW measurments 
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Figure 4.18: FTIR standard curve peaks 
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APPENDIX D: PATIENT CONSENT FORMS IN ENGLISH AND ISIZULU 
CONSENT FORM 
Study title: Study ofbioimpedance analysis in South African children 
Introduction: 
A group ofus (doctors and scientists) from the University of KwaZulu Natal in Durban and the St Luke's 
Roosevelt Hospital in New York, are doing research to see whether simple and inexpensive tests can be used 
in children to assess the percentage of fat and muscle in the body. These tests have already been done on 
adults locally. They have also been done on children in New York. 
This study involves research. In research scientists or doctors try to answer some important questions that 
may help improve the health of other babies and of the community at large. This research may not have direct 
benefit for your baby, but we expect the new information to have benefits for other babies in the future. 
Invitation to participate: 
You are being asked to allow your child to participate in a research study entitled "Study of bioimpedance 
analysis in South African children" because he/she is between 3 to 5 years old. 
Purpose of the Study: 
The purpose of this study is to assess whether simple and inexpensive tests can be used to assess the 
percentage of fat and muscle in the body. Other tests are too expensive and unavailable, too difficult to 
perfom1 in children, or may require blood to be drawn. In this study we will compare a test called 
'Bioimpedance Assessment', which is easy to perform and not painful, to a more expensive test called 
'isotope dilution', which is difficult to perform and involves taking blood. We are hoping that information 
from this study will enable us to use the simple, non-painful test for children rather than using other tests. 
The reasons for wanting to know how much muscle and fat children have in the body may be of use to 
doctors to see what effect different chronic illnesses have on children. It may also be used as simple way to 
check if children are responding to treatments. 
What is involved in the study: We will enroll 30 children in total from King Edward VIII Hospital in 
Durban. We will need to see your child only once for this study. We will perform a few measurements that 
involve measurement of weight and height, a procedure called BIA or bioimpedance assessment and drawing 
of blood before and 2 hours after drinking a special solution. We will also collect saliva at the same times 
that we collect blood. 
All of the procedures to evaluate your child have been used previously in research and clinical settings. 
Bioimpedance assessment involves passing a very small electric current through the body. Humans are 
unable to feel this, and it will be similar to having an ECG done. Electrodes will be placed on the wrists and 
feet to obtain a recording. It will not take longer than a few minutes. Thereafter we will draw some blood and 
collect saliva from your child. We will then give him/her a harmless solution to drink. This solution contains 
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a substance that we can measure in the blood and saliva that is not nomrnlly present in the body. The 
substance will eventually be eliminated from the body. Two hours after drinking this we will have to take 
another blood and saliva sample. The total volume of blood taken, 8ml (less than 2 teaspoons), and total 
volume of saliva taken, 4ml will not have any harmful effect on your child. 
Blood and saliva will be frozen and stored until the end of the study. Blood and saliva from all subjects will 
then be sent to a special laboratory in New York to be processed because there is no such facility in South 
Africa. The blood and saliva will only be used for the test described in this document. Any remainder will 
then be safely discarded. These results will not be immediately available. They will only become available 
after the study is completed. We will however inform you of the results by contacting you telephonically or 
in writing once we have interpreted these tests. The results will have no influence on the current treatment of 
your child. Specimens will not have your child's name on the label. They will have a code that only the 
researchers in this study will be able to link to your child. 
Risks of being involved in the study. Some of the risks of having blood drawn include soreness and 
bruising at the puncture site. At the site ofpunture, there may be a small risk of wound infection whenever 
blood is drawn. We will take every precaution to avoid this from happening. If this problem arises we will 
help you obtain the necessary care for your child. The other procedures have no risk associated with them. 
Benefits of being in the study. The study and tests will not benefit your child directly. Please do not confuse 
this with other tests and treatments that may be given at this clinic. You may ask if you are uncertain about 
what aspects are related to this study alone. We anticipate these tests to be of value in the care of other 
children in the future. 
Participation is voluntary. You may choose not to participate in this study. It will not have any bad effect 
on your baby's treatment or management, or involvement in other studies. 
Costs and Reimbursements: There are no direct costs to you. There are no direct financial incentives for 
participating in the sn1dy. We will provide you with a snack when waiting 2 hours for 
repeat testing. The study does not require repeated visits. We will provide you R20 as compensation for any 
inconvenience that the 2 hour wait may create. 
Confidentiality: Efforts will be made to keep personal information confidential. All forms and computers 
will be protected. Personal information may be disclosed if required by law. Organizations that may inspect 
and/or copy your research records for quality assurance and data analysis include groups such as the 
Research Ethics Committee. 
If results are published or presented at meetings, it may lead to group identification but the individual identity 
of you and your child will not be disclosed. 
This study has been approved by the Ethics Committee at the University of KwaZulu Natal in Durban and St 
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Luke's Roosevelt Center in New York. These committees are responsible for making sure that risks (if any) 
to the subject will be outweighed by potential benefit to the subject and/or to the importance of the 
information to be gained. They want to ensure that the rights and welfare of each person is adequately 
protected and that informed consent will be obtained. 
If you ever have questions about this study , or in the case of a research-related injury , you should contact 
the principal investigator Dr Meera Chhagan at (031) 260 4345, Department of Paediatrics and Child Health, 
Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 719 Umbilo Road, Congella, 4013 
Durban. 
You may contact the Biomedical Research Ethics Office at the Nelson R Mandela School of Medicine at 
(031) 260 4604 if you have questions about your rights as a research subject. The contact person is Ms
Suraiya Buccas and the chairperson is Professor Jack Moodley. The address of this office is: 
Medical Research Administration 
Nelson R Mandela School of Medicine 
University of KwaZulu-Natal 
719 Umbilo Road 
Congella, 4013 
Do you wish to ask any questions at this time? 
May I now ask you to sign this form consenting to your child being entered into this sh1dy and allowing us to 
perform these tests. 
We thank you for your co-operation and time. Please feel free to approach us should you have any queries in 
the future. We will give you a copy of this form. 
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SIGNATURES 
If you have read this consent form, or had it read and explained to you, and you understand the information, 




Participant Signature Date 
Study Staff Conducting 
Consent Discussion (print) 
Study Staff Signature Date 
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IMVUME EGUNYAZIWE 
lsihloko socwaningo: Ucwaningo lokucubunga i"bioimpedance" kubantwana base 
Ningizimu Afrika 
Isingeniso: 
lthimba lethu (odokotela kanye nososayensi) baseNyuvesi ya KwaZulu Natal eThekwini 
kanye nabase St Luke's Roosevelt Hospital e New York, senza ucwaningo ukubheka 
ukuthi kuhlola okulula nokungabizi kakhulu kungasetshenziswa ezinganeni ukuhlola inani 
lamafutha kanye nemisioha emzimbeni. Lokhu kuhlola sekuye kwenziwa vele kubantu 
abadala endaweni. Kwenziwe futhi kubantwana base New York. 
Lolucwaningo lumbandakanya uphenyo. Ophenyweni ososayensi noma odokotela bazama 
ukuphendula eminye imibuzo ebalulekile engasiza ukwenza ngcono impilo yabanye 
abantwana kanye neyomphakathi ngokubanzi. Loluphenyo ngeke lwaba nomhlomulo 
oqonde ngqo enganeni yakho, kodwa silindele ulwazi olusha lokuba nemihlomulo 
kwabanye abantwana ngokuzayo. 
Isimemo sokungenela: 
Uyacelwa ukuthi uvumele ingane yakho ukuthi ingenele ucwaningo lokwelapha olubizwqa 
ngokuthi yi "Study of bioimpedance lokucubungula izingabe zase Ningizimu Afrika" 
ngoba ineminyaka ephakathi kwemi 3 kuya kwemi 5 ubudala. 
Inhloso Yocwaningo: 
Inhloso yalolucwaningo ukubheka ukuthi ngabe ukuhlola okulula kanye nokungabizi 
kakhulu kungenziwa yini ukubheka inani lamafutha kanye nemisipha emzimbeni. Okunye 
ukuhlola kubiza kakhulu futhi akutholakali, kunzima kakhulu ukukwenza ezinganeni, 
noma kungadinga ukudonswa kwegazi. Kulolucwaningo siyoqhathanisa ukuhlola 
okubizwa ngokuthi yi 'Bioimpedance Assessment', okulula ukukwenza futhi 
okungenabuhlungu, sikuqhathanisa nalokho okubiza kakhulu okubizwa ngokuthi yi 
'isotope dilution', okunzima ukukwenza futhi kumbandakanya nokudonswa kwegazi. 
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Siyethemba ukuthi ulwazi eliluthola kulolucwaningo luyokwenza sikwazi ukwenza 
ukuhlola okulula, okungenabo ubuhlungu kubantwana kunokusebenzisa okunye ukuhlola. 
Izizathu zokufuna ukwazi ukuthi izingane zinemisipha kanye namafutha angakanani 
emzimbeni kungaba wusizo kodokotela ukubona yimuphi umphumela wezifo ezahlukene 
neziwumbelembele okubantwana. Ungasetshenziswa futhi njengendlela elula yokubheka 
ukuthi ngabe abantwana bayezwela yini emithini. 
Yini embandakanyeka ocwaningeni: Siyobhalisa abantwana abangama 30 bebonke 
abaphuma Esibhedlela iKing Edward VIII eThekwini. Siyodinga ukubona ingane yakho 
kanye kuphela ngalolucwaningo. Siyokwenza izilinganiso ezimbalwa ezimbandakanya 
ukulinganiswa kwesisindo somzimba kanye nesisindo somzimba, inqubo ebizwa ngokuthi 
yi BIA noma i bioimpedance assessment kanye nokudonswa kwegazi ngaphambi kanye 
nangemuva kwamahora ama 2 emva kokuphuza ingxube elungiselelwe. Siyoqoqa futhi 
amathe ngezikhathi ezifanayo esiqoqa ngazo igazi. Zonke izinqubo zokuhlola ingane 
yakho zike zasetshenziswa phambilini ocwaningeni kanye nasekuhleleleni ukwelashwa. 
I "Bioimpedance assessment" imbandakanya ukudlulisa okunogesi omncane emzimbeni. 
Abantu abakwazi ukuzwa lokhu, futhi kuyofana nokuhlolwa kokusebenza kwenhliziyo 
ngomshini we ECG. Okunogesi "ama- Electrodes" ayobekwa ezihlakaleni kanye 
nasezinyaweni ukuthola ukuqoshwa. Ngeke kuthathe ngaphezu kwemizuzu embalwa. 
Emva kwalokho siyodonsa igazi elithize bese siqoqa amathe enganeni yakho. Siyobe-ke 
sesiyinikeza ingxube ukuthi iyiphuze. Ingxube iqukethe utho esingalulinganisa egazini 
kanye nasemlonyeni olungavamile ukuba khona emzimbeni. Utho ekugcineni luyoqedwa 
emzimbeni. Emahoreni amabili emva kokuphuza lokhu kuyomele sithathe elinye igazi 
kanye nesampula lamathe. Inani lomthamo wegazi elithathwayo, u 8ml (ngaphansi 
kothesipuni aba 2), kanye nenani lomthamo wamathe athathwayo, u 4ml ngeke kube 
nomphumela wokulimazeka enganeni yakho. Igazi kanye namathe kuyoqandiswa bese 
kulondolozwa kuze kuphele ucwaningo. Igazi kanye namathe okuthathwe kwabangenele 
kuyobe sekuthunyelwa elabhorethi ekhethekile ese New York ukuthi kuyosetshenzwa 
ngoba asikho isikhungo esinjalo eNingizimu Afrika. 
Igazi kanye namathe kuyosetshenziselwa kuphela ukuhlola okuchazwe kulombhalo. Noma 
yikuphi okusilele kuyoshatshalaliswa ngendlela ephephile. Lemiphumela ngeke isheshe 
itholakale. lyotholakal kuphela emva kokuqedwa kocwaningo. Kodwa-ke siyokwazisa 
ngemiphumela ngokuthi sikushayele ucingo noma sikubhalele uma nje sesihumushe 
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lemiphumela. Imiphumela ngeke ibe nethonya ekulashweni kwengane yakho ekuthola 
ngalesi sikhathi. Amasampula ngeke abe negama lengane yakho elebulini. Ayoba nekhodi 
leyo okunganacwaningi kuphela abakulolucwaningo abayokwazi ukuluxhumanisa nengane 
yakho. 
Izingozi zokuba socwaningeni. Ezinye izingozi zokudonswa kwegazi zimbandakanya 
ubuhlungu kanye nomzizima endaweni okudonswe kuyo igazi. Kulendawo okudonswe 
kuyo, kungaba nengozi encane yokubhibha kwesilonda noma nini uma kudonswa igazi. 
Siyothatha izinyathelo zokuvikela ukugwema lokhu ukuthi kwenzeke. Uma kuvela 
lenkinga siyokusiza ukuthola ukunakekelwa okufanele kwengane yakho. Ezinye izinqubo 
azinazo izingozi ezihlobene nazo. 
Imihlomulo yokuba socwaningeni. Ucwaningo kanye nokuhlola ngeke kuyizuzele ingane 
yakho ngqo. Sicela ungaphambanisi lokhu nokunye ukuhlolwa kanye nemithi 
oenganikezwa yona kulomtholampilo. Ungabuza uma ungenaso isiqiniseko ngezinto 
ezihlobene nalolucwaningo lodwa. Silindele ukuthilokhu kuhlola kuya wusizo 
ekunakekelweni kwabanye abantwana ngomuso. 
Ukungenela kuya ngokuzithandela komuntu. Ungakhetha ukungalungeneli 
lolucwaningo. Ngeke kube nomphumela omubi ekwelashweni kwengane yakho noma 
ekuphathweni, noma ngokungenela ezinye izincwaningo. 
Izindleko kanye Nokubuyiselwa imali: Azikho izindleko eziqondene ngqo nawe. 
Ayikho imihlomulo yemali eqonde ngqo ngokungenela ucwaningo. Siyokuhlinzeka 
ngokudla okungatheni ngesikhathi usalinde amahora amabili ukuphinda ukuhlolwa. 
Ucwaningo aludingi ukuthi uphinde uvakashe. Siyokunikeza u R20 njengesinxephezelo 
sanoma yikuphi ukuxakeka okungadaleka emahore amabili usalindile. 
Ubumfihlo: Kuyokwenziwa imizamo yokugcina ulwazi lwakho luyimfihlo. Wonke 
amafomu kanye namakhompuyutha kyovikelwa. Ulwazi lwakho lungadalulwa uma 
kudingwa ngumthetho. Izinhlangano ezingahlola kanye/noma zenze imifanekiso 
yamarekhodi ocwaningo ukuqinisekisa ngezikha kanye nokucutshungulwa kwemidanti 
yolwazi zimbandakanya amaqembu afana Nekomiti Locwaningo Lenkambiso enble. 
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Uma imiphumela ishicilelwa noma yethulwa emihlanganweni, kungaholela ekudalulweni 
kwethimba kodwa ukudalulwa komuntu ngamunye kwegama lakho kanye nelengane 
yakho ngeke kudalulwe. 
Lolucwaningo lugunyazwe Yikomiti Lenkambiso enhle eliseNyuvesi ya KwaZulu Natal 
eThekwini kanye nabe St Luke's Roosevelt Center e New York. Lamakomiti anesibopho 
sokuqinisekisa ukuthi izingozi (uma zikhona) esigulini ziyokwedlulwa ngumhlomulo 
ongaba khona esigulini kanye/noma ekubalulekeni kolwazi oluzozizwa. Bafuna 
ukuqinisekisa ukuthi amalungelo kanye nehlalakahle yomuntu ngamunye ayovikelwa 
ngokulinganayo futhi kuyotholwa imvume egunyaziwe. 
Uma unemibuzo maqondana nalolucwaningo , noma uma kuba khona ukulimala 
okuhlobene nocwaningo, kumele uxhumane nomphenyi omkhulu uDkt Meera Chhagan 
kulenombolo yocingo (031) 260 4345 noma (031) 260 4600, ku Department of Paediatrics 
and Child Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, 
719 Umbilo Road, Congella, 4013 Durban. 
UNgaxhumana nabe Biomedical Research Ethics Office e Nelson R Mandela School of 
Medicine kulenombolo yocingo (031) 260 4604 uma unemibuzo maqondana namalungelo 
akho njengongenele ucwaningo. Umuntu oxhunywayo ngu Ms Suraiya Buccas kanye 
nosihlalo uPholofesa Jack Moodley. Ikheli lalelihhovisi lithi: 
Medical Research Administration 
Nelson R Mandela School of Medicine 
University of KwaZulu-Natal 
719 Umbilo Road 
Congella, 4013 
Ngabe uyafisa ukubuza eminye imibuzo ngalesi sikhathi? 
Manje angikucele ukuthi usayine lelifomu lokuvumela ingane yak.ho ukuthi ifakwe 
kulolucwaningo kanye nokusivuela ukuthi sense lokhu kulohla. 
Siyabonga ukusebenzisana nathi kanye nesikhathi sakho. Siza ukhululeke ukusithinta uma 
uba nanoma yimiphi imibuzo ngokuzayo. Siyokunikeza ikhophi yalelifomu. 
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AMASIGNESHA 
Uma usufunde lelifomu lemvume, noma ufundelwe Iona futhi wachazelwa lonau, futhi 
uluqonda ulwazi, futhi ngokuzithandela kwakho uvuma ukuthi ingane yakho ingenele 





Ingxoxo Y emvume 
(bhala wehlukanise) 
Isignesha Yongenele Usuku 




APPENDIX E : DAT A COLLECTION FORM 
PERSONAL DETAILS 
ASSIGNED STUDY NUMBER: 
-----
Patient Name (Surname first): 
--------------
Patient hospital Number: ___ _ 
Clinic number: 
-----
Patient date of birth 
------






Caregiver name: ___________ _ 
NUTRITIONAL ASSESSMENT 




CLINICAL FEATURES OF MALNUTRITION 
Mid upper arm circumference (triplicate): 
mm mm 
--- ---
___ mm mm 
---
___ mm ___ mm 
















___ mm mm 
Visible signs of wasting: YIN ________________ _ 
Visible edema: YIN
---------------
Skin/hairmagnifications of kwashiorkor: YIN _________ _ 
Thrush present: YIN ___________ _ 
Any other lesions in the mouth? YIN _________ _ 
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Diarrhoea: Y /N 
Signs of dehydration: YIN
Skin temperature: ___ _ 
Record details of all fluids ingested within the last two hours: 
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APPENDIX F : ETHICS APPROVAL 
25 January 2008 
Dr M K Chhagan 
Paediatrics 
Nelson R Mandela School of Medicine 




BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Nelson R Mandela School of Medicine 
Private Bag 7, Congella 4013 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 )1 2604769 
Fax: 27 31 2604609 
EmaH: buccaS@l1kzn.ac.za 
Webslte: www.ukzn .. _ac.za 
PROTOCOL: Study of bioimpedance analysis in South African children. M K
Chhagan, Paediatrics. Ref: E049/05 
A sub-committee of the Biomedical Research Ethics Committee has considered and 
noted your response received on 26th March 2008 to queries raised on 25 January 
2008. 
We acknowledge receipt of the Export permit which expires on 31 December 2008
and a declaration that no genetic testing will be done on the saliva. These 
conditions have now been met and the study is given full ethics approval and may
begin as at 30 April 2008. 
This approval is valid for one year from 30 April 2008. To ensure continuous 
approval, an application for recertification should be submitted a couple of months 
before the expiry date. In addition, when consent is a requirement, the consent 
process will need to be repeated annually. 
I take this opportunity to wish you everything of the best with your study. Please 




Prof. D Wassenaar 
Chair: Biomedical Research Ethics Committee
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